0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HIV Antibody Diagnostic Reagent Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-18V14589
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global HIV Antibody Diagnostic Reagent Market Research Report 2023
BUY CHAPTERS

Global HIV Antibody Diagnostic Reagent Market Research Report 2025

Code: QYRE-Auto-18V14589
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

HIV Antibody Diagnostic Reagent Market Size

The global market for HIV Antibody Diagnostic Reagent was valued at US$ 428 million in the year 2024 and is projected to reach a revised size of US$ 600 million by 2031, growing at a CAGR of 5.0% during the forecast period.

HIV Antibody Diagnostic Reagent Market

HIV Antibody Diagnostic Reagent Market

HIV Antibody Diagnostic Reagent is a reagent used to detect HIV
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for HIV Antibody Diagnostic Reagent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Antibody Diagnostic Reagent.
The HIV Antibody Diagnostic Reagent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HIV Antibody Diagnostic Reagent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV Antibody Diagnostic Reagent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of HIV Antibody Diagnostic Reagent Market Report

Report Metric Details
Report Name HIV Antibody Diagnostic Reagent Market
Accounted market size in year US$ 428 million
Forecasted market size in 2031 US$ 600 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Abbott, Bio-Rad Laboratories, Danaher, BD, Atomo Diagnostics, BioSURE UK, Biosynex, bioLytical Laboratories, OraSure Technologies, Chembio Diagnostic Systems, Inc., Sedia Biosciences Corporation, Asan Pharm, Getein Biotech, AccuBio Tech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of HIV Antibody Diagnostic Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of HIV Antibody Diagnostic Reagent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is HIV Antibody Diagnostic Reagent Market growing?

Ans: The HIV Antibody Diagnostic Reagent Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the HIV Antibody Diagnostic Reagent Market size in 2031?

Ans: The HIV Antibody Diagnostic Reagent Market size in 2031 will be US$ 600 million.

Who are the main players in the HIV Antibody Diagnostic Reagent Market report?

Ans: The main players in the HIV Antibody Diagnostic Reagent Market are Roche, Abbott, Bio-Rad Laboratories, Danaher, BD, Atomo Diagnostics, BioSURE UK, Biosynex, bioLytical Laboratories, OraSure Technologies, Chembio Diagnostic Systems, Inc., Sedia Biosciences Corporation, Asan Pharm, Getein Biotech, AccuBio Tech

What are the Application segmentation covered in the HIV Antibody Diagnostic Reagent Market report?

Ans: The Applications covered in the HIV Antibody Diagnostic Reagent Market report are Hospital, Clinic

What are the Type segmentation covered in the HIV Antibody Diagnostic Reagent Market report?

Ans: The Types covered in the HIV Antibody Diagnostic Reagent Market report are ELISA, Chemiluminescence, Immunofluorescence Test

Recommended Reports

HIV Diagnostics & Reagents

Disease Rapid Diagnostics

Immunoassays & Reagents

1 HIV Antibody Diagnostic Reagent Market Overview
1.1 Product Definition
1.2 HIV Antibody Diagnostic Reagent by Type
1.2.1 Global HIV Antibody Diagnostic Reagent Market Value Comparison by Type (2024 VS 2031)
1.2.2 ELISA
1.2.3 Chemiluminescence
1.2.4 Immunofluorescence Test
1.3 HIV Antibody Diagnostic Reagent by Application
1.3.1 Global HIV Antibody Diagnostic Reagent Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global HIV Antibody Diagnostic Reagent Market Size Estimates and Forecasts
1.4.1 Global HIV Antibody Diagnostic Reagent Revenue 2020-2031
1.4.2 Global HIV Antibody Diagnostic Reagent Sales 2020-2031
1.4.3 Global HIV Antibody Diagnostic Reagent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 HIV Antibody Diagnostic Reagent Market Competition by Manufacturers
2.1 Global HIV Antibody Diagnostic Reagent Sales Market Share by Manufacturers (2020-2025)
2.2 Global HIV Antibody Diagnostic Reagent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global HIV Antibody Diagnostic Reagent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of HIV Antibody Diagnostic Reagent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HIV Antibody Diagnostic Reagent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HIV Antibody Diagnostic Reagent, Product Type & Application
2.7 Global Key Manufacturers of HIV Antibody Diagnostic Reagent, Date of Enter into This Industry
2.8 Global HIV Antibody Diagnostic Reagent Market Competitive Situation and Trends
2.8.1 Global HIV Antibody Diagnostic Reagent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HIV Antibody Diagnostic Reagent Players Market Share by Revenue
2.8.3 Global HIV Antibody Diagnostic Reagent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HIV Antibody Diagnostic Reagent Market Scenario by Region
3.1 Global HIV Antibody Diagnostic Reagent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global HIV Antibody Diagnostic Reagent Sales by Region: 2020-2031
3.2.1 Global HIV Antibody Diagnostic Reagent Sales by Region: 2020-2025
3.2.2 Global HIV Antibody Diagnostic Reagent Sales by Region: 2026-2031
3.3 Global HIV Antibody Diagnostic Reagent Revenue by Region: 2020-2031
3.3.1 Global HIV Antibody Diagnostic Reagent Revenue by Region: 2020-2025
3.3.2 Global HIV Antibody Diagnostic Reagent Revenue by Region: 2026-2031
3.4 North America HIV Antibody Diagnostic Reagent Market Facts & Figures by Country
3.4.1 North America HIV Antibody Diagnostic Reagent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America HIV Antibody Diagnostic Reagent Sales by Country (2020-2031)
3.4.3 North America HIV Antibody Diagnostic Reagent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe HIV Antibody Diagnostic Reagent Market Facts & Figures by Country
3.5.1 Europe HIV Antibody Diagnostic Reagent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe HIV Antibody Diagnostic Reagent Sales by Country (2020-2031)
3.5.3 Europe HIV Antibody Diagnostic Reagent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HIV Antibody Diagnostic Reagent Market Facts & Figures by Region
3.6.1 Asia Pacific HIV Antibody Diagnostic Reagent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific HIV Antibody Diagnostic Reagent Sales by Region (2020-2031)
3.6.3 Asia Pacific HIV Antibody Diagnostic Reagent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HIV Antibody Diagnostic Reagent Market Facts & Figures by Country
3.7.1 Latin America HIV Antibody Diagnostic Reagent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America HIV Antibody Diagnostic Reagent Sales by Country (2020-2031)
3.7.3 Latin America HIV Antibody Diagnostic Reagent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa HIV Antibody Diagnostic Reagent Market Facts & Figures by Country
3.8.1 Middle East and Africa HIV Antibody Diagnostic Reagent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa HIV Antibody Diagnostic Reagent Sales by Country (2020-2031)
3.8.3 Middle East and Africa HIV Antibody Diagnostic Reagent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HIV Antibody Diagnostic Reagent Sales by Type (2020-2031)
4.1.1 Global HIV Antibody Diagnostic Reagent Sales by Type (2020-2025)
4.1.2 Global HIV Antibody Diagnostic Reagent Sales by Type (2026-2031)
4.1.3 Global HIV Antibody Diagnostic Reagent Sales Market Share by Type (2020-2031)
4.2 Global HIV Antibody Diagnostic Reagent Revenue by Type (2020-2031)
4.2.1 Global HIV Antibody Diagnostic Reagent Revenue by Type (2020-2025)
4.2.2 Global HIV Antibody Diagnostic Reagent Revenue by Type (2026-2031)
4.2.3 Global HIV Antibody Diagnostic Reagent Revenue Market Share by Type (2020-2031)
4.3 Global HIV Antibody Diagnostic Reagent Price by Type (2020-2031)
5 Segment by Application
5.1 Global HIV Antibody Diagnostic Reagent Sales by Application (2020-2031)
5.1.1 Global HIV Antibody Diagnostic Reagent Sales by Application (2020-2025)
5.1.2 Global HIV Antibody Diagnostic Reagent Sales by Application (2026-2031)
5.1.3 Global HIV Antibody Diagnostic Reagent Sales Market Share by Application (2020-2031)
5.2 Global HIV Antibody Diagnostic Reagent Revenue by Application (2020-2031)
5.2.1 Global HIV Antibody Diagnostic Reagent Revenue by Application (2020-2025)
5.2.2 Global HIV Antibody Diagnostic Reagent Revenue by Application (2026-2031)
5.2.3 Global HIV Antibody Diagnostic Reagent Revenue Market Share by Application (2020-2031)
5.3 Global HIV Antibody Diagnostic Reagent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche HIV Antibody Diagnostic Reagent Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott HIV Antibody Diagnostic Reagent Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Bio-Rad Laboratories
6.3.1 Bio-Rad Laboratories Company Information
6.3.2 Bio-Rad Laboratories Description and Business Overview
6.3.3 Bio-Rad Laboratories HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bio-Rad Laboratories HIV Antibody Diagnostic Reagent Product Portfolio
6.3.5 Bio-Rad Laboratories Recent Developments/Updates
6.4 Danaher
6.4.1 Danaher Company Information
6.4.2 Danaher Description and Business Overview
6.4.3 Danaher HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Danaher HIV Antibody Diagnostic Reagent Product Portfolio
6.4.5 Danaher Recent Developments/Updates
6.5 BD
6.5.1 BD Company Information
6.5.2 BD Description and Business Overview
6.5.3 BD HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BD HIV Antibody Diagnostic Reagent Product Portfolio
6.5.5 BD Recent Developments/Updates
6.6 Atomo Diagnostics
6.6.1 Atomo Diagnostics Company Information
6.6.2 Atomo Diagnostics Description and Business Overview
6.6.3 Atomo Diagnostics HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Atomo Diagnostics HIV Antibody Diagnostic Reagent Product Portfolio
6.6.5 Atomo Diagnostics Recent Developments/Updates
6.7 BioSURE UK
6.7.1 BioSURE UK Company Information
6.7.2 BioSURE UK Description and Business Overview
6.7.3 BioSURE UK HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BioSURE UK HIV Antibody Diagnostic Reagent Product Portfolio
6.7.5 BioSURE UK Recent Developments/Updates
6.8 Biosynex
6.8.1 Biosynex Company Information
6.8.2 Biosynex Description and Business Overview
6.8.3 Biosynex HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biosynex HIV Antibody Diagnostic Reagent Product Portfolio
6.8.5 Biosynex Recent Developments/Updates
6.9 bioLytical Laboratories
6.9.1 bioLytical Laboratories Company Information
6.9.2 bioLytical Laboratories Description and Business Overview
6.9.3 bioLytical Laboratories HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 bioLytical Laboratories HIV Antibody Diagnostic Reagent Product Portfolio
6.9.5 bioLytical Laboratories Recent Developments/Updates
6.10 OraSure Technologies
6.10.1 OraSure Technologies Company Information
6.10.2 OraSure Technologies Description and Business Overview
6.10.3 OraSure Technologies HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.10.4 OraSure Technologies HIV Antibody Diagnostic Reagent Product Portfolio
6.10.5 OraSure Technologies Recent Developments/Updates
6.11 Chembio Diagnostic Systems, Inc.
6.11.1 Chembio Diagnostic Systems, Inc. Company Information
6.11.2 Chembio Diagnostic Systems, Inc. Description and Business Overview
6.11.3 Chembio Diagnostic Systems, Inc. HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Chembio Diagnostic Systems, Inc. HIV Antibody Diagnostic Reagent Product Portfolio
6.11.5 Chembio Diagnostic Systems, Inc. Recent Developments/Updates
6.12 Sedia Biosciences Corporation
6.12.1 Sedia Biosciences Corporation Company Information
6.12.2 Sedia Biosciences Corporation Description and Business Overview
6.12.3 Sedia Biosciences Corporation HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sedia Biosciences Corporation HIV Antibody Diagnostic Reagent Product Portfolio
6.12.5 Sedia Biosciences Corporation Recent Developments/Updates
6.13 Asan Pharm
6.13.1 Asan Pharm Company Information
6.13.2 Asan Pharm Description and Business Overview
6.13.3 Asan Pharm HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Asan Pharm HIV Antibody Diagnostic Reagent Product Portfolio
6.13.5 Asan Pharm Recent Developments/Updates
6.14 Getein Biotech
6.14.1 Getein Biotech Company Information
6.14.2 Getein Biotech Description and Business Overview
6.14.3 Getein Biotech HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Getein Biotech HIV Antibody Diagnostic Reagent Product Portfolio
6.14.5 Getein Biotech Recent Developments/Updates
6.15 AccuBio Tech
6.15.1 AccuBio Tech Company Information
6.15.2 AccuBio Tech Description and Business Overview
6.15.3 AccuBio Tech HIV Antibody Diagnostic Reagent Sales, Revenue and Gross Margin (2020-2025)
6.15.4 AccuBio Tech HIV Antibody Diagnostic Reagent Product Portfolio
6.15.5 AccuBio Tech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HIV Antibody Diagnostic Reagent Industry Chain Analysis
7.2 HIV Antibody Diagnostic Reagent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HIV Antibody Diagnostic Reagent Production Mode & Process Analysis
7.4 HIV Antibody Diagnostic Reagent Sales and Marketing
7.4.1 HIV Antibody Diagnostic Reagent Sales Channels
7.4.2 HIV Antibody Diagnostic Reagent Distributors
7.5 HIV Antibody Diagnostic Reagent Customer Analysis
8 HIV Antibody Diagnostic Reagent Market Dynamics
8.1 HIV Antibody Diagnostic Reagent Industry Trends
8.2 HIV Antibody Diagnostic Reagent Market Drivers
8.3 HIV Antibody Diagnostic Reagent Market Challenges
8.4 HIV Antibody Diagnostic Reagent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global HIV Antibody Diagnostic Reagent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global HIV Antibody Diagnostic Reagent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global HIV Antibody Diagnostic Reagent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global HIV Antibody Diagnostic Reagent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global HIV Antibody Diagnostic Reagent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global HIV Antibody Diagnostic Reagent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global HIV Antibody Diagnostic Reagent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market HIV Antibody Diagnostic Reagent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of HIV Antibody Diagnostic Reagent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of HIV Antibody Diagnostic Reagent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of HIV Antibody Diagnostic Reagent, Product Type & Application
 Table 12. Global Key Manufacturers of HIV Antibody Diagnostic Reagent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global HIV Antibody Diagnostic Reagent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Antibody Diagnostic Reagent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global HIV Antibody Diagnostic Reagent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global HIV Antibody Diagnostic Reagent Sales by Region (2020-2025) & (K Units)
 Table 18. Global HIV Antibody Diagnostic Reagent Sales Market Share by Region (2020-2025)
 Table 19. Global HIV Antibody Diagnostic Reagent Sales by Region (2026-2031) & (K Units)
 Table 20. Global HIV Antibody Diagnostic Reagent Sales Market Share by Region (2026-2031)
 Table 21. Global HIV Antibody Diagnostic Reagent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global HIV Antibody Diagnostic Reagent Revenue Market Share by Region (2020-2025)
 Table 23. Global HIV Antibody Diagnostic Reagent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global HIV Antibody Diagnostic Reagent Revenue Market Share by Region (2026-2031)
 Table 25. North America HIV Antibody Diagnostic Reagent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America HIV Antibody Diagnostic Reagent Sales by Country (2020-2025) & (K Units)
 Table 27. North America HIV Antibody Diagnostic Reagent Sales by Country (2026-2031) & (K Units)
 Table 28. North America HIV Antibody Diagnostic Reagent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America HIV Antibody Diagnostic Reagent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe HIV Antibody Diagnostic Reagent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe HIV Antibody Diagnostic Reagent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe HIV Antibody Diagnostic Reagent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe HIV Antibody Diagnostic Reagent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe HIV Antibody Diagnostic Reagent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific HIV Antibody Diagnostic Reagent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific HIV Antibody Diagnostic Reagent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific HIV Antibody Diagnostic Reagent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific HIV Antibody Diagnostic Reagent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific HIV Antibody Diagnostic Reagent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America HIV Antibody Diagnostic Reagent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America HIV Antibody Diagnostic Reagent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America HIV Antibody Diagnostic Reagent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America HIV Antibody Diagnostic Reagent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America HIV Antibody Diagnostic Reagent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa HIV Antibody Diagnostic Reagent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa HIV Antibody Diagnostic Reagent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa HIV Antibody Diagnostic Reagent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa HIV Antibody Diagnostic Reagent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa HIV Antibody Diagnostic Reagent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global HIV Antibody Diagnostic Reagent Sales (K Units) by Type (2020-2025)
 Table 51. Global HIV Antibody Diagnostic Reagent Sales (K Units) by Type (2026-2031)
 Table 52. Global HIV Antibody Diagnostic Reagent Sales Market Share by Type (2020-2025)
 Table 53. Global HIV Antibody Diagnostic Reagent Sales Market Share by Type (2026-2031)
 Table 54. Global HIV Antibody Diagnostic Reagent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global HIV Antibody Diagnostic Reagent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global HIV Antibody Diagnostic Reagent Revenue Market Share by Type (2020-2025)
 Table 57. Global HIV Antibody Diagnostic Reagent Revenue Market Share by Type (2026-2031)
 Table 58. Global HIV Antibody Diagnostic Reagent Price (US$/Unit) by Type (2020-2025)
 Table 59. Global HIV Antibody Diagnostic Reagent Price (US$/Unit) by Type (2026-2031)
 Table 60. Global HIV Antibody Diagnostic Reagent Sales (K Units) by Application (2020-2025)
 Table 61. Global HIV Antibody Diagnostic Reagent Sales (K Units) by Application (2026-2031)
 Table 62. Global HIV Antibody Diagnostic Reagent Sales Market Share by Application (2020-2025)
 Table 63. Global HIV Antibody Diagnostic Reagent Sales Market Share by Application (2026-2031)
 Table 64. Global HIV Antibody Diagnostic Reagent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global HIV Antibody Diagnostic Reagent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global HIV Antibody Diagnostic Reagent Revenue Market Share by Application (2020-2025)
 Table 67. Global HIV Antibody Diagnostic Reagent Revenue Market Share by Application (2026-2031)
 Table 68. Global HIV Antibody Diagnostic Reagent Price (US$/Unit) by Application (2020-2025)
 Table 69. Global HIV Antibody Diagnostic Reagent Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche HIV Antibody Diagnostic Reagent Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Abbott Company Information
 Table 76. Abbott Description and Business Overview
 Table 77. Abbott HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Abbott HIV Antibody Diagnostic Reagent Product
 Table 79. Abbott Recent Developments/Updates
 Table 80. Bio-Rad Laboratories Company Information
 Table 81. Bio-Rad Laboratories Description and Business Overview
 Table 82. Bio-Rad Laboratories HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bio-Rad Laboratories HIV Antibody Diagnostic Reagent Product
 Table 84. Bio-Rad Laboratories Recent Developments/Updates
 Table 85. Danaher Company Information
 Table 86. Danaher Description and Business Overview
 Table 87. Danaher HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Danaher HIV Antibody Diagnostic Reagent Product
 Table 89. Danaher Recent Developments/Updates
 Table 90. BD Company Information
 Table 91. BD Description and Business Overview
 Table 92. BD HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. BD HIV Antibody Diagnostic Reagent Product
 Table 94. BD Recent Developments/Updates
 Table 95. Atomo Diagnostics Company Information
 Table 96. Atomo Diagnostics Description and Business Overview
 Table 97. Atomo Diagnostics HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Atomo Diagnostics HIV Antibody Diagnostic Reagent Product
 Table 99. Atomo Diagnostics Recent Developments/Updates
 Table 100. BioSURE UK Company Information
 Table 101. BioSURE UK Description and Business Overview
 Table 102. BioSURE UK HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. BioSURE UK HIV Antibody Diagnostic Reagent Product
 Table 104. BioSURE UK Recent Developments/Updates
 Table 105. Biosynex Company Information
 Table 106. Biosynex Description and Business Overview
 Table 107. Biosynex HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Biosynex HIV Antibody Diagnostic Reagent Product
 Table 109. Biosynex Recent Developments/Updates
 Table 110. bioLytical Laboratories Company Information
 Table 111. bioLytical Laboratories Description and Business Overview
 Table 112. bioLytical Laboratories HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. bioLytical Laboratories HIV Antibody Diagnostic Reagent Product
 Table 114. bioLytical Laboratories Recent Developments/Updates
 Table 115. OraSure Technologies Company Information
 Table 116. OraSure Technologies Description and Business Overview
 Table 117. OraSure Technologies HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. OraSure Technologies HIV Antibody Diagnostic Reagent Product
 Table 119. OraSure Technologies Recent Developments/Updates
 Table 120. Chembio Diagnostic Systems, Inc. Company Information
 Table 121. Chembio Diagnostic Systems, Inc. Description and Business Overview
 Table 122. Chembio Diagnostic Systems, Inc. HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Chembio Diagnostic Systems, Inc. HIV Antibody Diagnostic Reagent Product
 Table 124. Chembio Diagnostic Systems, Inc. Recent Developments/Updates
 Table 125. Sedia Biosciences Corporation Company Information
 Table 126. Sedia Biosciences Corporation Description and Business Overview
 Table 127. Sedia Biosciences Corporation HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Sedia Biosciences Corporation HIV Antibody Diagnostic Reagent Product
 Table 129. Sedia Biosciences Corporation Recent Developments/Updates
 Table 130. Asan Pharm Company Information
 Table 131. Asan Pharm Description and Business Overview
 Table 132. Asan Pharm HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Asan Pharm HIV Antibody Diagnostic Reagent Product
 Table 134. Asan Pharm Recent Developments/Updates
 Table 135. Getein Biotech Company Information
 Table 136. Getein Biotech Description and Business Overview
 Table 137. Getein Biotech HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Getein Biotech HIV Antibody Diagnostic Reagent Product
 Table 139. Getein Biotech Recent Developments/Updates
 Table 140. AccuBio Tech Company Information
 Table 141. AccuBio Tech Description and Business Overview
 Table 142. AccuBio Tech HIV Antibody Diagnostic Reagent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. AccuBio Tech HIV Antibody Diagnostic Reagent Product
 Table 144. AccuBio Tech Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. HIV Antibody Diagnostic Reagent Distributors List
 Table 148. HIV Antibody Diagnostic Reagent Customers List
 Table 149. HIV Antibody Diagnostic Reagent Market Trends
 Table 150. HIV Antibody Diagnostic Reagent Market Drivers
 Table 151. HIV Antibody Diagnostic Reagent Market Challenges
 Table 152. HIV Antibody Diagnostic Reagent Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of HIV Antibody Diagnostic Reagent
 Figure 2. Global HIV Antibody Diagnostic Reagent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global HIV Antibody Diagnostic Reagent Market Share by Type: 2024 & 2031
 Figure 4. ELISA Product Picture
 Figure 5. Chemiluminescence Product Picture
 Figure 6. Immunofluorescence Test Product Picture
 Figure 7. Global HIV Antibody Diagnostic Reagent Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global HIV Antibody Diagnostic Reagent Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Global HIV Antibody Diagnostic Reagent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global HIV Antibody Diagnostic Reagent Market Size (2020-2031) & (US$ Million)
 Figure 13. Global HIV Antibody Diagnostic Reagent Sales (2020-2031) & (K Units)
 Figure 14. Global HIV Antibody Diagnostic Reagent Average Price (US$/Unit) & (2020-2031)
 Figure 15. HIV Antibody Diagnostic Reagent Report Years Considered
 Figure 16. HIV Antibody Diagnostic Reagent Sales Share by Manufacturers in 2024
 Figure 17. Global HIV Antibody Diagnostic Reagent Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest HIV Antibody Diagnostic Reagent Players: Market Share by Revenue in HIV Antibody Diagnostic Reagent in 2024
 Figure 19. HIV Antibody Diagnostic Reagent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global HIV Antibody Diagnostic Reagent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America HIV Antibody Diagnostic Reagent Sales Market Share by Country (2020-2031)
 Figure 22. North America HIV Antibody Diagnostic Reagent Revenue Market Share by Country (2020-2031)
 Figure 23. United States HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe HIV Antibody Diagnostic Reagent Sales Market Share by Country (2020-2031)
 Figure 26. Europe HIV Antibody Diagnostic Reagent Revenue Market Share by Country (2020-2031)
 Figure 27. Germany HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific HIV Antibody Diagnostic Reagent Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific HIV Antibody Diagnostic Reagent Revenue Market Share by Region (2020-2031)
 Figure 34. China HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America HIV Antibody Diagnostic Reagent Sales Market Share by Country (2020-2031)
 Figure 42. Latin America HIV Antibody Diagnostic Reagent Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa HIV Antibody Diagnostic Reagent Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa HIV Antibody Diagnostic Reagent Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE HIV Antibody Diagnostic Reagent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of HIV Antibody Diagnostic Reagent by Type (2020-2031)
 Figure 52. Global Revenue Market Share of HIV Antibody Diagnostic Reagent by Type (2020-2031)
 Figure 53. Global HIV Antibody Diagnostic Reagent Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of HIV Antibody Diagnostic Reagent by Application (2020-2031)
 Figure 55. Global Revenue Market Share of HIV Antibody Diagnostic Reagent by Application (2020-2031)
 Figure 56. Global HIV Antibody Diagnostic Reagent Price (US$/Unit) by Application (2020-2031)
 Figure 57. HIV Antibody Diagnostic Reagent Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Feline Infectious Peritonitis (FIP) Antivirals Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4U20267
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global Anticoccidial Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-16R16865
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Bacterial Enteric Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-3F17301
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Whooping Cough Vaccination Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-4B20221
Wed Nov 12 00:00:00 UTC 2025

Add to Cart